GenMont Biotech Incorporation announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was TWD 99.476 million compared to TWD 78.454 million a year ago. Operating income was TWD 21.245 million compared to TWD 17.535 million a year ago. Net income was TWD 14.751 million compared to TWD 15.146 million a year ago. Basic earnings per share was TWD 0.17 compared to TWD 0.17 a year ago. For the half year, sales was TWD 203.242 million compared to TWD 158.974 million a year ago. Operating income was TWD 60.285 million compared to TWD 36.881 million a year ago. Net income was TWD 45.355 million compared to TWD 24.063 million a year ago. Basic earnings per share was TWD 0.53 compared to TWD 0.27 a year ago. Diluted earnings per share was TWD 0.52 compared to TWD 0.27 a year ago.